Translating molecules into imaging—the development of new pet tracers for patients with melanoma

HIGHLIGHTS

• who: Laetitia Vercellino et al. from the Nuclear Medicine Department, University Hospital Saint-Louis, Assistance Publique-Hu00f4pitaux de, Unitu00e9 Claude Kellershohn, Institut de Recherche Saint-Louis, Universitu00e9 de, France have published the research: Translating Molecules into Imagingu2014The Development of New PET Tracers for Patients with Melanoma, in the Journal: Diagnostics 2022, 1116 of /2022/
• what: The authors focus on novel imaging agents; however, often there is a companion therapeutic treatment using the same targeting molecule and a therapy radionuclide, which the authors briefly touch upon in the text. One option to attempt to predict response . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.